Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
No LLNA test has been performed as a reliable non-LLNA skin sensitising assay has already been available.

Test material

Constituent 1
Chemical structure
Reference substance name:
Butylamine
EC Number:
203-699-2
EC Name:
Butylamine
Cas Number:
109-73-9
Molecular formula:
C4H11N
IUPAC Name:
butan-1-amine
Test material form:
liquid
Details on test material:
- Name of test material (as cited in study report): Mono-n-butylamine
- Physical state: liquid, colourless
- Analytical purity: 99.2 %
- Lot/batch No.: tank 21 from continuous production
- Storage condition of test material: room temperature

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Pirbright White, Dunkin Hartley HOE DHPK [SPF-LACJ
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Lippische Versuchstierzucht, Hagemann GmbH & Co. KG, Germany
- Age at study initiation: young adults
- Weight at study initiation: 301 - 350 g
- Housing: 5 animals in Makrolon, type IV cages
- Diet: Kliba Labordiaet 341, ad libitum
- Water: tap water ad libitum (about 2 g of ascorbic acid per 10 l water was added to the drinking water twice a week)
- Acclimation period: 7 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
water
Concentration / amount:
Intradermal induction: test substance 5%
Intradermal induction: test substance 0.1%
Percutaneous induction: test substance 5% in aqua bidest.

Challengeopen allclose all
Route:
epicutaneous, open
Vehicle:
water
Concentration / amount:
Challenge: test substance 2% in aqua bidest.
No. of animals per dose:
Control group: 10
Test group: 20
Details on study design:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 6 intradermal injections in groups of two per animal and one percutaneous exposure 1 week after intradermal induction.
- Exposure period: percutaneous exposure: 48 h
- Test groups: 12 animals
- Control group: 6 animals
- Site: shoulder


B. CHALLENGE EXPOSURE
- No. of exposures: single percutaneous exposure
- Day(s) of challenge: 24 h
- Site: intact flank
- Concentrations: 2x2 cm filter paper strips containing the test substance.
- Evaluation (hr after challenge): 24 h and 48 h after removal of the patch.
Positive control substance(s):
yes
Remarks:
Performed in a separate study twice a year in the laboratory with 1-Chloro-2,4-dinitrobenzene

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
2 %
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no effects
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no effects.
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
2 %
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no effects
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no effects.
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
2 %
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no effects
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
2 %
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no effects
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
1 %
No. with + reactions:
20
Total no. in group:
20
Clinical observations:
erythema and edema
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 1 %. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: erythema and edema.

Any other information on results incl. tables

Maximization Test:

Challenge Test group:

 Form of application: right flank: 2% in aqua bidest.  

                                                       
Animal No.  1  2  3  4  5  6  7  8  10 11 12  13  14  15  16  17  18  19  20     
Findings 24 h after removal of the patch 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0  0/0 0/0 0/0  0/0  0/0  0/0  0/0  0/0  0/0     
Findings 48 h after removal of the patch 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0  0/0  0/0  0/0 0/0  0/0  0/0  0/0  0/0     

Erythema/Edema

After the intradermal induction with 5% test substance preparations well-defined erythema and slight edema were observed at the injection sites of the control group animals and test group animals at which only Freund's adjuvant / 0.9% aqueous NaCl-solution (1:1) was applied. Injection of the test substance preparation in 0.9% aqueous NaCl-solution caused necrotic skin changes in addition to slight edema in few injection sites and well-defined erythema and very slight edema in almost all injection sites of the animals of the test group. Necrotic skin changes and slight edema or well defined erythema and slight edema could be observed after application of the test substance preparation in Freund's adjuvant / 0.9% aqueous NaCl-solution (1 :1) in the test group animals.

 

The control group animals which were treated with 0.9% aqueous NaCl-solution did not show any skin reactions.

 

After the percutaneous induction with a 5% test substance preperations necrotic skin changes, partially open (caused by the intradermal induction) in addition to slight edema could be observed.

 

The challenge with the 2% test substance preparations in aqua bidest. did not cause any skin reaction in all animals.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the conditions of the study the test item was not sensitising.
Executive summary:

In a guinea pig maximisation test according to OECD guideline 406 the animals (20 in test group, 10 controls) were subjected to 6 intradermal induction treatments with 0.1% test substance in aqua bidest, or 0.1% in Freund's adjuvant/aqua bidest (1:1) or Freund's adjuvant/aqua bidest (1:1) without test substance. Percutaneous induction was performed 1 week after the last induction with 5% test substance in aqua bidest. The animals were challenged with 2% in aqua bidest. and skin reaction examined 24 and 48 h after treatment. No positive reactions were observed.